Brief: Alembic Pharma Q4 Consol Profit 1.57 Bln Rupees
06/05/2025 09:23
May 6 (Reuters) - Alembic Pharmaceuticals Ltd ALEM.NS: Q4 CONSOL PROFIT 1.57 BILLION RUPEES Q4 CONSOL REVENUE FROM OPERATIONS 17.70 BILLION RUPEES DIVIDEND OF 11 RUPEES PER SHARE Source text: [ID:] Further company coverage: ALEM.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Alembic Pharmaceuticals
See all newsIndia's Alembic Pharma rises after US FDA approves herpesvirus drug
Brief: Alembic Pharmaceuticals Receives USFDA Final Approval For Valganciclovir Oral Solution 50 Mg/Ml
Brief: Alembic Pharmaceuticals Completes USFDA Bioequivalence Inspection At Vadodara With No Observations
India's Alembic Pharma gains as brokerages optimistic after quarterly profit rise
India's Alembic Pharma posts quarterly profit rise on strong generics demand